- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Stryker opens Neurovascular lab to accelerate stroke-related innovation in Asia Pacific
Stroke is a leading cause of death and disability worldwide, with more than 58 million of those cases recorded in Asia.
Gurugram: Stryker, a medical technology company, has recently opened its Neurovascular (NV) lab, a state-of-the-art lab designed to accelerate stroke-related innovation in Asia Pacific.
Located within the Stryker Global Technology Center (SGTC) at International Park, Gurgaon, India, the Keystone Suite will enable collaboration between customers, product development engineers, cross-functional teams, and other key stakeholders.
Stroke is a leading cause of death and disability worldwide, with more than 58 million of those cases recorded in Asia. In India, scarcity of professional care and infrastructure are key factors in the country's treatment rates. This lab offers an ideal environment for medical education, research and development, and customer engagement activities designed to improve patient outcomes.
Read also: Medical device maker Stryker gets US antitrust nod to buy Wright Medical Group
The NV lab has three main components: a neurovascular catheterization lab designed to mimic the hospital treatment experience with the latest imaging and communication equipment; a performance lab with hands-on stations outfitted with flow models, neurovascular simulators, and 3D model printing capabilities; and planned space for physician interaction.
Read also: Medical device maker Stryker to buy Vocera Communications for 2.97 Billion USD
Mark O'Brien, Vice President and General Manager for the Neurovascular Division at Stryker, said, "Asia Pacific is our fastest growing region, and a big part of our future growth plans. We are continuing to invest in the region to facilitate innovation and advance stroke care."
Ram Rangarajan, Vice President of Stryker Global Technology Center, said, "We're excited to bring this advanced lab and its capabilities to India's neurointerventionalist community and to help grow the specialty in country. We believe in the concept of public-private partnerships and invite the government to collaborate with us to train future physicians."
Stryker established its first R&D facility in India more than 15 years ago.
Read also: Stryker India MD Meenakshi Nevatia joins APACMed as Chairperson for India Executive Committee
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751